Orca Bio
Chemicals & Related Products · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
3475 Edison Way Ste C, Menlo Park, Calif...Phone Number
(650) 246-9601Website
www.orcabio.comRevenue
$73.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
1
1
1
1
About Orca Bio
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of blood cancer and autoimmune diseases. The companys manufacturing platform uses single-cell precision to create personalized cell therapy products intended to replace a patients diseased blood and immune system with a healthy one. At Orca Bio, we are on a mission to redefine whats possible for patients by transforming the field of curative allogeneic cell therapy.Explore more
Orca Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Orca Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Orca Bio has recently received funding, and reach out quickly before it becomes old news!
Click to see if Orca Bio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Orca Bio has new funding data
Congratulate Masked Content for being promoted to Masked Content at Orca Bio
Earning: See what the market has to say on Orca Bio recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Orca Bio is spiking on competitors!
Product Launch: Get notified when Orca Bio launches new products
Orca Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Orca Bio
Compare insights from companies similar to Orca Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Orca Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Orca Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Orca Bio.
Orca Bio financials insights
Gather financial insights about Orca Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series D
$192M
2026
Series F
$250M
Orca Bio Tech Stack
A closer look at the technologies used by Orca Bio
Most Recent Scoops
Hiring Plans
Orca Bio has more open roles in Human Resources than it has had at any time in the past 6 months.
Hiring Plans
Open Position
Open Position
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Orca Bio News & Media
Orca Bio Banks $250M Series F Funding
MENLO PARK, CA, Orca Bio announced the completion of a Series F financing round in December 2025, led by Lightspeed Venture Partners. With $250M in new equity capital from its two most recent financing rounds.Orca Bio Appoints Key Executives Including Steve Gavel as Chief Commercial Officer
MENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the appointment of senior leaders to support the company as it advances its lead investigational allogeneic T-cell immunotherapy, Orca-T®, toward potential commercial launch. Steve Gavel has joined Orca Bio as Chief Commercial Officer after most recently serving as Senior Vice President, Global Cell Therapy CommercOrca Bio Announces Leadership Updates
MENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the appointment of the company’s co-founder and Chief Scientific Officer, Nate Fernhoff, Ph.D., as Chief Executive Officer (CEO), succeeding Ivan Dimov, Ph.D. In addition, co-founder and Chief Operating Officer, Jeroen Bekaert, Ph.D., has assumed the role of President. “I am honored and humbled to serve as CEO as w
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Orca Bio
Sign Up For FreeTo access detailed company insights
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of blood cancer and autoimmune diseases. The companys manufacturing platform uses single-cell precision to create personalized cell therapy products intended to replace a patients diseased blood and immune system with a healthy one. At Orca Bio... Read More
